ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
CLAE: A High-Fidelity Nanopore Sequencing Strategy for Read-Level Viral Variant Detection and Environmental RNA Virus Discovery.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Testicular mRNA-LNP Delivery: A Novel Therapy for Genetic Spermatogenic Disorders.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Current status and prospects of nanopore sequencing technology in the detection of pathogenic microorganisms.Frontiers in microbiology · 2026Review
- Oxford Nanopore Sequencing in pediatric emergency infectious diseases: from rapid diagnosis to precision medicine.Frontiers in cellular and infection microbiology · 2026Review
- Engineering Anti-Tumor Immunity: An Immunological Framework for mRNA Cancer Vaccines.Vaccines · 2025Review
- CLAE: A High-Fidelity Nanopore Sequencing Strategy for Read-Level Viral Variant Detection and Environmental RNA Virus Discovery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
High-fidelity (HF) long-read sequencing enables accurate profiling of microorganisms and pathogens at single-molecule resolution. However, current Oxford Nanopore Technologies (ONT)-a revolutionary platform offering real-time, portable sequencing at relatively low instrumental cost-suffer from severe read-length bias, limited accuracy (often <Q20), and low throughput. Here, Circular- and Linear-Amplicon-Mediated Error Correction (CLAE) is introduced, a biochemical and computational approach that addresses these limitations by integrating hairpin ligation, pre-circling, single-stranded DNA linearization, and targeted nickase-based debranching. CLAE significantly enhances rolling-circle amplification (RCA) efficiency for long DNA templates, markedly improving Nanopore sequencing yield and accuracy. CLAE achieves Q30-level accuracy in up to 27% of RCA reads, throughput exceeding 800 Mb per 100 pores, and an N50 of ≈15 Kb (bacterial genome). Moreover, its bidirectional subreads and high throughput substantially boost accuracy without compromising read length. CLAE is validated by resolving SARS-CoV-2 quasi-species from community wastewater and recovering novel, full-length RNA virus genomes from marine samples. CLAE enables precise variant detection in complex samples and corrects short-read misassemblies, significantly broadening ONT's utility in metaviromics, epidemiology, and environmental surveillance. Thus, CLAE establishes a versatile, field-compatible platform for high-fidelity viral genome sequencing in targeted and agnostic contexts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.